No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects (Q90863550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

title

No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

0 references

1 reference

1 reference

Taylor Choi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

Allison S Komirenko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

Valerie Riddle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

Aryun Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

Shyeilla V Dhuria

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

publication date

3 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

Clinical pharmacology in drug development

17 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

page(s)

818-826

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

Synthesis and spectrum of the neoglycoside ACHN-490

17 April 2020

cites work

1 reference

7 January 2021

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin

1 reference

7 January 2021

Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes.

1 reference

7 January 2021

Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes

1 reference

7 January 2021

In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).

1 reference

7 January 2021

Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis: A Multicenter, Randomized, Double-Blind, Phase 2 Study

1 reference

7 January 2021

Pharmacokinetics and safety of single and multiple doses of ACHN-490 injection administered intravenously in healthy subjects

1 reference

7 January 2021

A Phase 1 Study to Assess the Pharmacokinetics of Intravenous Plazomicin in Adult Subjects with Varying Degrees of Renal Function

1 reference

7 January 2021

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

1 reference

7 January 2021

Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers

1 reference

7 January 2021

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

1 reference

7 January 2021

Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects

1 reference

7 January 2021

The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers

1 reference

7 January 2021

8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2018.

1 reference

7 January 2021

Clinical Pharmacokinetics of Metformin

1 reference

7 January 2021

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

7 January 2021

Pharmacokinetics of metformin after intravenous and oral administration to man

1 reference

7 January 2021

Reduction of metformin renal tubular secretion by cimetidine in man

1 reference

7 January 2021

Effect of Ondansetron on Metformin Pharmacokinetics and Response in Healthy Subjects

1 reference

7 January 2021

The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice

1 reference

7 January 2021

Membrane transporters in drug development

1 reference

7 January 2021

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

7 January 2021

Transporters and drug-drug interactions: important determinants of drug disposition and effects

1 reference

7 January 2021

The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?

1 reference

7 January 2021

Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients

1 reference

7 January 2021

Evaluation of transporters in drug development: Current status and contemporary issues

1 reference

7 January 2021

Identifiers

DOI

10.1002/CPDD.648

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30605260 AND SRC:MED&resulttype=core&format=json

17 April 2020

1 reference